Abstract
Prognostic Implications of Minimal Residual Disease Detection in Acute Myeloid Leukemia (AML) with Cytarabine Based Therapy of Differing Dose Intensities
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have